Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy

Author:  ["Norbert Frey","Tomasa Barrientos","John M Shelton","Derk Frank","Hartmut Rütten","Doris Gehring","Christian Kuhn","Matthias Lutz","Beverly Rothermel","Rhonda Bassel-Duby","James A Richardson","Hugo A Katus","Joseph A Hill","Eric N Olson"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

Signaling by the calcium-dependent phosphatase calcineurin profoundly influences the growth and gene expression of cardiac and skeletal muscle. Calcineurin binds to calsarcins, a family of muscle-specific proteins of the sarcomeric Z-disc, a focal point in the pathogenesis of human cardiomyopathies. We show that calsarcin-1 negatively modulates the functions of calcineurin, such that calcineurin signaling was enhanced in striated muscles of mice that do not express calsarcin-1. As a consequence of inappropriate calcineurin activation, mice with a null mutation in calsarcin-1 showed an excess of slow skeletal muscle fibers. The absence of calsarcin-1 also activated a hypertrophic gene program, despite the absence of hypertrophy, and enhanced the cardiac growth response to pressure overload. In contrast, cardiac adaptation to other hypertrophic stimuli, such as chronic catecholamine stimulation or exercise, was not affected. These findings show important roles for calsarcins as modulators of calcineurin signaling and the transmission of a specific subset of stress signals leading to cardiac remodeling in vivo.

Cite this article

Frey, N., Barrientos, T., Shelton, J. et al. Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat Med 10, 1336–1343 (2004). https://doi.org/10.1038/nm1132

View full text

>> Full Text:   Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy

Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumors

Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection